Counterfeit diabetes, weight-loss drugs raise alarm after series of fatalities

Novo Nordisk, maker of the weight-loss and Type 2 diabetes drugs Ozempic and Wegovy, cautioned this week that counterfeit versions of the drugs’ active ingredient, semaglutide, may be linked to at least 10 deaths and over 100 hospitalizations…